None
Quote | Mirum Pharmaceuticals Inc. (NYSE:MIRM)
Last: | $ |
---|---|
Change Percent: | -4.60% |
Open: | $17.33 |
Close: | $16.40 |
High: | $17.38 |
Low: | $16.37 |
Volume: | 79,847 |
Last Trade Date Time: | 02/12/2020 04:43:03 pm |
News | Mirum Pharmaceuticals Inc. (NYSE:MIRM)
Submission based on the positive Phase 3 RESTORE study Mirum holds orphan designation for chenodiol in CTX Potential to have first and only therapy indicated for CTX in the US Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced the submission of a new drug application (ND...
2024-06-27 16:48:49 ET Summary The small biotech sector has badly underperformed the major market indices so far in 2024. However, that could change as the Federal Reserve cuts interest rates and/or M&A deal volume picks up across the industry. Today, we highlight three sm...
Message Board Posts | Mirum Pharmaceuticals Inc. (NYSE:MIRM)
Subject | By | Source | When |
---|---|---|---|
I agree ! | Ganz | investorshub | 01/30/2023 4:46:13 PM |
I'm not sure there's a more intriguing small | historyperson | investorshub | 01/30/2023 1:45:09 AM |
Float, smote, keep an eye on this one. | Ganz | investorshub | 01/25/2023 4:55:43 PM |
The float is so small | Cosa | investorshub | 01/23/2023 7:05:41 PM |
Riztheinvestor: CYDY buyout 50 bucks 2023 | Riztheinvestor | investorshangout | 04/06/2022 7:39:11 PM |
News, Short Squeeze, Breakout and More Instantly...
Mirum Pharmaceuticals Inc. Company Name:
MIRM Stock Symbol:
NYSE Market:
Mirum Pharmaceuticals Inc. Website:
Submission based on the positive Phase 3 RESTORE study Mirum holds orphan designation for chenodiol in CTX Potential to have first and only therapy indicated for CTX in the US Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced the submission of a new drug application (ND...
2024-06-23 05:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-17 16:15:02 ET Evercore ISI analyst issues OUTPERFORM recommendation for MIRM on June 17, 2024 03:27PM ET. The previous analyst recommendation was Outperform. MIRM was trading at $32.76 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...